(Q66409496)
Statements
Phase 2, Randomized, Multi-Center, Double-Blind, Dose-Ranging, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety/Pharmacokinetics of BMS-986142 in Subjects With Moderate to Severe Rheumatoid Arthritis With an Inadequate Response to Methotrexate With or Without TNF Inhibitors (English)
0 references
16 February 2016
0 references
3 May 2018
0 references
508
0 references
18 year
0 references
120 year
0 references